Sage Journals: Discover world-class research

Abstract

Medicinal cannabis is legal in some form in 47 states, 3 United States territories, and the District of Columbia. An estimated three million Americans use cannabis for relief of a variety of illnesses, and this figure is expected to grow based on policy changes. However, cannabis remains illegal at the federal level as a Schedule I drug under the 1970 Controlled Substances Act. Schedule I classification of cannabis has impeded the advancement of research, leaving providers with little evidence-based information to educate their patients. Furthermore, the disparities in individual state laws create significant social and health inequities in gaining access to medicinal cannabis. Conflicting state and federal policies regarding medicinal cannabis create logistical and ethical dilemmas, and all U.S. stakeholders—patients, providers, and health delivery systems—may be impacted by conflicting federal and state policies. This brief addresses the impact of conflicting cannabis policies.

Keywords

medicinal cannabis policy controlled substances patients research Schedule I drug

Get full access to this article

View all access options for this article.

References

American Academy of Pediatrics. (2015). The impact of marijuana policies on youth: Clinical, research, and legal update. Pediatrics, 135(3), 584–587.

American Civil Liberties Union. (2014). War comes home: The excessive militarization of American policing.

American Civil Liberties Union (2020) A tale of two countries. Racially targeted arrests in the era of marijuana reform.

Americans for Safe Access. (2019a). 2019 State of the states report. An analysis of medical cannabis access in the United States. https://www.safeaccessnow.org/sos

Americans for Safe Access. (2019b). Facing state or federal charges? https://www.safeaccessnow.org/are_you_facing_state_or_federal_charges

American Nurses Association. (2016). Therapeutic use of marijuana and related cannabinoids. Position statement. https://www.nursingworld.org/∼49a8c8/globalassets/practiceandpolicy/ethics/therapeutic-use-of-marijuana-and-related-cannabinoids-position-statement.pdf

Aggarwal

S. K.

Carter

G. T.

Sullivan

M. D.

ZumBrunnen

Morrill

Mayer

J. D.

(2009). Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions. Journal of Opioid Management, 5(3), 153–168.

Ben Amar

(2006). Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology, 105(1–2), 1–25. https://doi.org/10.1016/j.jep.2006.02.001

Bostwick

J. M.

(2012). Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clinic Proceedings, 87(2), 172–186. https://doi.org/10.1016/j.mayocp.2011.10.003

10.

Carlini

Carter

Roffman

Takahashi

R. N.

(2017). Medicinal cannabis and chronic pain. Science based education in times of legalization. University of Washington Alcohol and Drug Abuse Institute. https://adai.uw.edu/mcacp/

11.

Compton

(2017). Marijuana-impaired driving – A report to congress (DOT HS 812 440). National Highway Traffic Safety Administration. https://www.nhtsa.gov/sites/nhtsa.dot.gov/files/documents/812440-marijuana-impaired-driving-report-to-congress.pdf

12.

Cooper

(2015). War on drugs and police brutality. Substance Use and Misuse, 50(8–9), 1188–1194. https://doi.org/10.3109/10826084.2015.1007669

13.

Department of Veterans Affairs. (2017). Access to VHA clinical programs for veterans participating in state-approved marijuana programs (VHA DIRECTIVE 1315). https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=5711

14.

Devinsky

Cross

J. H.

Laux

Marsh

Miller

Nabbout

Scheffer

I. E.

Thiele

E. A.

Wright

(2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376(21), 2011–2020. https://doi.org/10.1056/NEJMoa1611618

15.

Drug Enforcement Administration. (2016a). Applications to become registered under the Controlled Substances Act to manufacture marijuana to supply researchers in the United States. https://www.federalregister.gov/documents/2016/08/12/2016-17955/applications-to-become-registered-under-the-controlled-substances-act-to-manufacture-marijuana-to

16.

Drug Enforcement Administration. (2016b). Denial of petition to initiate proceedings to reschedule marijuana. https://www.federalregister.gov/documents/2016/08/12/2016-17954/denial-of-petition-to-initiate-proceedings-to-reschedule-marijuana

17.

Durkin

(2017, January). Medical marijuana … in the hospital? ACP Hospitalist. https://acphospitalist.org/archives/2017/01/marijuana-policies-hospital.htm

18.

Gowen

Cahill

Russell

Cronquist

(2018). Medical marijuana and nursing practice: Current legislation, scientific literature review, and nursing implications. National Council of State Boards of Nursing. https://www.ncsbn.org/2018DCM_Medical- Marijuana.pdf

19.

Hampson

J. A.

Axelrod

Grimaldi

(2003). Cannabinoids as antioxidants and neuroprotectants (U.S. Patent No. US6630507B1). U.S. Department of Health and Human Services. https://patents.google.com/patent/US6630507B1/en

20.

Hellerman

(2017, March 8). Scientists say the government’s only pot farm has moldy samples — and no federal testing standards. PBS News Hour. https://www.pbs.org/newshour/nation/scientists-say-governments-pot-farm-moldy-samples-no-guidelines

21.

Joseph

P. E.

(2020, May 29). From the Black Panthers to Black Lives Matter, the ongoing fight to end police violence against black Americans. The Washington Post. https://www.washingtonpost.com/nation/2020/05/29/black-panthers-black-lives-matter-ongoing-fight-end-police-violence-against-black-americans/

22.

Mason

Leavitt

Chafee

(Eds.). (2012). Policy and politics in nursing and health care (6th ed., p. 346). Elsevier.

23.

Miller

(2020, March 30). After 4-year delay, DEA will review dozens of requests to grow marijuana for research. Science Magazine. https://www.sciencemag.org/news/2020/03/after-4-year-delay-dea-will-review-dozens-requests-grow-marijuana-research

24.

Musto

D. F.

(1972). The Marihuana Tax Act of 1937. Archives of General Psychiatry, 26(2), 101–108. https://doi.org/10.1001/archpsyc.1972.01750200005002

25.

National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. The National Academies Press. https://doi.org/10.17226/24625

26.

National Conference of State Legislatures. (2020, March 10). State medical marijuana laws. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx

27.

Pergam

S. A.

Woodfield

M. C.

Lee

C. M.

Cheng

G. S.

Baker

K. K.

Marquis

S. R.

Fann

J. R.

(2017). Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer, 123(22), 4488–4497. https://doi.org/10.1002/cncr.30879

28.

Room

(2005). Stigma, social inequality and alcohol and drug use. Drug Alcohol Review, 24(2), 143–155. https://doi.org/10.1080/09595230500102434

29.

Russell

Cahill

Gowen

Cronquist

Smith

Borris-Hale

Fischer

Heywood

Johnston

Sutton-Johnson

(2018). The National Council of State Boards of Nursing national nursing guidelines for medical marijuana. Journal of Nursing Regulation, 9(2), S2–S52.

30.

Ryan, J. E., Noeder, M., Burke, C., Stubblefield, S. C., Sulieman, S., & Miller, E. G. (2019). Denying renal transplantation to an adolescent medical cannabis user: An ethical case study. Pediatr Transplant, e13467. doi:10.1111/petr.13467

31.

Ryan

J. E.

Sharts-Hopko

N. C.

(2017). The experiences of medical marijuana patients: A scoping review of the qualitative literature. Journal of Neuroscience Nursing, 49(3), 185–190. https://doi.org/10.1097/jnn.0000000000000283

32.

Sessions

J. B.

(2018). Memorandum for all United States Attorneys; Marijuana Enforcement. https://www.justice.gov/opa/press-release/file/1022196/download

33.

Victor

(2018, May 30). They let their 15-year-old son smoke pot to stop his seizures. Georgia took him away. The New York Times. https://www.nytimes.com/2018/05/30/us/marijuana-seizures-child-services.html

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB